Herbas VPB

Print
EN | LT
LT - PHARMACEUTICAL COMPOSITIONS COMPRISING A MACROCYCLIC QUINOXALINE COMPOUND WHICH IS AN HCV NS3 PROTEASE INHIBITOR
EN - PHARMACEUTICAL COMPOSITIONS COMPRISING A MACROCYCLIC QUINOXALINE COMPOUND WHICH IS AN HCV NS3 PROTEASE INHIBITOR

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61P 31/14
A61K 38/06
A61K 38/07
A61K 38/08
C07K 5/08
C07K 5/10
C07K 5/12
European patent
(11) Number of the document 2540349
(13) Kind of document T
(96) European patent application number 12181533.6
Date of filing the European patent application 2009-07-17
(97) Date of publication of the European application 2013-01-02
(45) Date of publication and mention of the grant of the patent 2014-02-12
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
135559 P 2008-07-22 US
Inventors
(72)
Harper, Steven, IT
Summa, Vincenzo, IT
Liverton, Nigel J., US
McCauley, John A., US
Grantee
(73) Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065, US
MSD Italia S.r.l., Via Vitorchiano, 151, 00189 Rome, IT
Title
(54) PHARMACEUTICAL COMPOSITIONS COMPRISING A MACROCYCLIC QUINOXALINE COMPOUND WHICH IS AN HCV NS3 PROTEASE INHIBITOR
  PHARMACEUTICAL COMPOSITIONS COMPRISING A MACROCYCLIC QUINOXALINE COMPOUND WHICH IS AN HCV NS3 PROTEASE INHIBITOR
Last update date 2021-04-30